|
CASC5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.070300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.815500E-03 |
| Normal-vs-Stage2 |
5.481700E-02 |
| Normal-vs-Stage3 |
5.845900E-02 |
| Normal-vs-Stage4 |
8.924000E-01 |
| Stage1-vs-Stage2 |
6.216200E-01 |
| Stage1-vs-Stage3 |
3.636800E-01 |
| Stage1-vs-Stage4 |
1.373780E-02 |
| Stage2-vs-Stage3 |
8.134200E-01 |
| Stage2-vs-Stage4 |
7.013800E-02 |
| Stage3-vs-Stage4 |
8.417700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.590100E-02 |
| Normal-vs-AfricanAmerican |
1.88405999999031E-05 |
| Normal-vs-Asian |
8.519200E-01 |
| Caucasian-vs-AfricanAmerican |
2.22689999999082E-05 |
| Caucasian-vs-Asian |
5.934200E-01 |
| AfricanAmerican-vs-Asian |
3.203000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.050000E-02 |
| Normal-vs-Female |
6.902400E-03 |
| Male-vs-Female |
1.348770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.699600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.785700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.186200E-02 |
| Normal-vs-Age(81-100Yrs) |
9.443400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.091600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.926400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.862590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.426200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.545900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.468200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.118090E-03 |
| Normal-vs-Grade 2 |
3.041700E-03 |
| Normal-vs-Grade 3 |
1.221710E-02 |
| Normal-vs-Grade 4 |
5.958800E-01 |
| Grade 1-vs-Grade 2 |
1.689210E-01 |
| Grade 1-vs-Grade 3 |
9.342300E-02 |
| Grade 1-vs-Grade 4 |
3.380400E-03 |
| Grade 2-vs-Grade 3 |
6.698600E-01 |
| Grade 2-vs-Grade 4 |
1.691540E-02 |
| Grade 3-vs-Grade 4 |
2.480100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.640100E-03 |
| Normal-vs-ccB subtype |
2.821600E-01 |
| ccA subtype-vs-ccB subtype |
2.524200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.311700E-02 |
| Normal-vs-N1 |
4.659800E-01 |
| N0-vs-N1 |
8.885900E-02 |
|
|
